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Introduction
Early human embryo mortality is a matter of considerable inter-
est not only to reproductive biologists and fertility doctors, but 
also to philosophers1,2, theologians3 and lawyers4. Most espe-
cially, becoming pregnant and having children is of overwhelming 
and personal importance to many women and their families. As 
with all biological processes, nothing works perfectly all the 
time5, and failure to conceive and pregnancy loss are common prob-
lems. However, among reputable scientific publications, including 
medical and reproductive biology text books, scientific reviews 
and primary research articles, reported mortality estimates are 
surprisingly varied and include: 30–70%6, >50%7 and 75%8 
before and during implantation; >50%9, 73%10 and 80%11 
before the 6th week; 75% before the 8th week12; 70% in the first 
trimester13; 40–50% in the first 20 weeks14; and 46%7, 49%15, 
50%16–18, >50%19,20, 53%21, 54%22, 60%23, >60%24, 63%25,26, 
70%27–31, 50–75%32, 76%10,33, 78%34, 80–85%35, >85%36, and 
90%37 total loss from fertilisation to term. The variance in these 
estimates is striking and the scale of some implausible. 90% 
intrauterine mortality implies a maximal live birth fecundabil-
ity of 10%, and only then if all other stages of the reproductive 
process are 100% efficient. Observed human fecundability is 
low compared to other animals21, but at approximately 20–30%9,38 
it is still higher than implied by such a high embryo mortality 
rate. Such inconsistent estimates of pregnancy loss are not reas-
suring, nor do they provide a sound basis for either a quantitative 
understanding of natural human reproductive biology or an unbi-
ased appraisal of artificial reproductive technologies. These 
divergent and excessive values therefore invite scrutiny of the 
evidence that supports them. In this article, I identify and re-
evaluate published data that contribute to claims regarding natural 
human embryo mortality. Using the available data, I attempt to 
answer the question: “How many human embryos die between 
fertilisation and birth under natural conditions?”
A quantitative framework for embryo mortality
A quantitative framework has recently been proposed to 
facilitate the calculation and comparison of embryo mortalities 
from fecundability and pregnancy loss data39. Briefly, the model 
comprises conditional probabilities (π) of the following biological 
processes: (1) reproductive behaviours resulting in sperm-
ovum-co-localisation per cycle = π
SOC
; (2) successful fertilisa-
tion given sperm-ovum-co-localisation = π
FERT
; (3) implantation 
of a fertilised ovum as indicated by increased levels of human 
chorionic gonadotrophin (hCG) = π
HCG
; (4) progression of an 
implanted embryo to a clinically recognised pregnancy = π
CLIN
; 
(5) survival of a clinical pregnancy to live birth = π
LB
.
Fecundability (FEC) is the probability of reproductive success 
per cycle, but may take different values depending on the defini-
tion of success. The following four fecundabilities broadly follow 
Leridon (1977)38:
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Hence, the probability that a fertilised egg will perish prior to 
implantation is [1 - π
HCG





)]. In theory, embryonic mortality may be esti-
mated at different stages; however, in practice, this depends on 
available data. Clinical and live birth fecundabilities are most 
easily quantified and most frequently reported. Total and detect-
able fecundabilities are less frequently reported, although of 
direct relevance.
BOX 1. Glossary of Key Reproductive Terms
  1.    Ovum: A female gamete, also known as an egg or oocyte. 
Ova (pl) are produced by the ovaries of the woman.
  2.    Spermatozoon: A male gamete. Sperm (or spermatozoa, 
pl) are produced in the testes of the man.
  3.    Ovulation: The release of an ovum from the ovary. In 
humans, ovulation usually involves the release of a single 
egg in each menstrual cycle.
  4.    Fallopian tube: A narrow tubular extension of the uterus, 
which opens out next to the ovary. It is also called the 
oviduct. Following ovulation, the ovum passes into the 
opening of the fallopian tube and travels towards the uterus.
  5.    Coitus: An act of sexual intercourse between a man and 
woman, usually resulting in the deposition of sperm within 
the reproductive tract of the woman.
  6.    Menstrual cycle: An interval of approximately 28 days, 
which commences with the onset of menstruation. Ovulation 
occurs mid-way though a menstrual cycle, approximately 
14 days before the onset of the next cycle.
  7.    Amenorrhoea: The absence of menstruation. A missed 
menstrual period is often the first observable sign that 
pregnancy has commenced, although there are many other 
causes.
  8.    Fertile period: The time in a woman’s menstrual cycle 
during which coitus may result in pregnancy. This period 
probably varies considerably between women. Coitus up 
to 6 days prior to and 1 day after ovulation may result in 
pregnancy although the most fertile days are the day of 
ovulation and the 2 days beforehand40.
      Amendments from Version 1
Version 2 has a new figure and glossary to assist readers and 
help them to follow the timings of key reproductive events.
Sections of text in the Introduction and Discussion have been 
re-ordered.
In text dates have been provided to aid with understanding of the 
chronology of studies.
A brief commentary on a study into implantation by Brosens et al. 
(2014) has been included.
Methods for the Roberts & Lowe simulation study, the calculation 
of bootstrap confidence intervals, and the calculation of estimated 
loss from implantation to birth have been clarified.
Comments have been included to note value in Roberts & Lowe’s 
analysis, to affirm the significance of Leridon’s critique, and to 
better contextualise the subjects from Hertig’s study.
Some additional studies have been referenced.
See referee reports
REVISED
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To aid understanding of the reproductive processes described in this 
article definitions of key terms have been provided in Box 1, and 
Figure 1 illustrates the timelines for key biological events associ-
ated with fecund and non-fecund cycles.
What the data say
Publications containing data relevant to early human embryo 
mortality were identified primarily by manually tracing cita-
tions found in articles, reviews and textbooks. A PubMed search 
(“early pregnancy loss” [All Fields]) identified some, but not all 
relevant studies. Certain studies were not conducted to address the 
specific question, and others are in books or publications that are 
not adequately indexed. If not entirely complete, nevertheless the 
data presented form a substantial proportion of relevant, available 
scientific data on natural early human embryo mortality.
Studies that contribute analysis and data relevant to the quantifica-
tion of natural human embryo mortality fall into the following four 
categories and will be considered in turn.
1.  A speculative hypothesis published in The Lancet.
2.  Life tables of intra-uterine mortality.
3.  Studies of early pregnancy by biochemical detection of hCG.
4.  Anatomical studies of Dr Arthur Hertig and Dr John Rock.
1. Where have all the conceptions gone?
In 1975, a short hypothesis published in The Lancet entitled 
“Where Have All The Conceptions Gone?” concluded that 78% of 
all conceptions were lost before birth34. It has been widely cited 
by both scientists9,25,27,28,41 and non-scientists42,43 alike. Concep-
tions among married women aged 20–29 in England and Wales 
in 1971 were estimated and compared to infants born in the same 
period. In this analysis (Table 1) there are reliable values, e.g., 
census data, and simple arithmetical calculations. However, spec-
ulative values are necessary to perform the calculations. Three 
are biological: (1) fertilisation rate following unprotected coitus 
during the fertile period was estimated as 50% and supported by 
reference to Hertig44 (although his estimate was 84%5); (2) the 
length of a menstrual cycle (28 days); and (3) the duration of 
the fertile period (2 days). These latter values are plausible, but 
also variable (Figure 1). No justification is provided for three 
behavioural variables: (1) coital frequency estimated at twice 
per week; (2) proportion of unprotected coital acts estimated at 
25%; and (3) either a random or regular distribution of coital acts 
during menstrual cycles such that 1/14 of all coital acts fall within 
a fertile period.
The validity of Roberts & Lowe’s conclusion depends largely 
on the accuracy and precision of these speculative values. The 
following two simple analyses illustrate the sensitivity of their 
conclusion on the speculative values.
1.    When four of the speculative values are reduced by 25% 
(e.g., coital frequency reduced to 1.5/week) and cycle 
  9.    Fertilization: The fusion of a spermatozoon and an ovum, 
which usually takes place in the fallopian tube up to 24 
hours after ovulation.
10.    Conception: A biologically imprecise term meaning either 
‘the coming into existence of a new human being’ or ‘the 
beginning of a pregnancy’. It is often used synonymously 
with fertilisation but may also refer to implantation.
11.    Embryo: A newly fertilised ovum until the eighth week of 
development.
12.    Zygote: The newly fertilised ovum: a one-cell embryo.
13.    Blastocyst: An embryo approximately 5–6 days after 
fertilisation.
14.    Implantation: The biological process that begins when a 
blastocyst attaches to the lining of the uterus approximately 
6–7 days after fertilisation. The embryo subsequently 
becomes embedded within the uterine lining.
15.    Human chorionic gonadotrophin (hCG): A protein 
produced by the embryo. It signals to the mother that an 
embryo is present and prevents menstruation and the loss 
of the embryo. Elevated levels of hCG can be detected 
in the serum or urine of a woman from around the time of 
implantation.
16.    Fecundability: A measure of reproductive potential. It is 
the probability of becoming pregnant in a single menstrual 
cycle. Fecundity is often used to mean the probability of 
achieving a live birth in a single cycle. A fecund cycle is 
one in which fertilisation occurs.
17.    Pregnancy: The condition of a woman harbouring an 
embryo, fetus or unborn child. When pregnancy begins 
is a matter of some confusion7 (Figure 1). Pregnancy may 
be considered to commence with fertilisation and lasts 
approximately 38 weeks. Clinicians often time the onset 
of pregnancy from day 1 of the last menstrual cycle, 2 
weeks before fertilisation, and refer to subsequent time 
as a period of gestation. On this account, pregnancy or 
gestation lasts approximately 40 weeks. Some scientists 
and legal judgements define pregnancy as beginning with 
implantation, one week after fertilisation. This definition 
is of particular utility in the context of IVF treatment 
where evidence of implantation is the earliest sign that a 
transferred embryo has developed normally and that fertility 
treatment has, up to that point, been successful. For some 
women, the start of a pregnancy may be noted with the 
first missed menstrual period, approximately 2 weeks after 
fertilisation, or a positive pregnancy test.
18.    Miscarriage: The premature termination of a pregnancy 
leading to loss of a developing embryo or fetus. Embryo 
loss may occur before a woman knows she is pregnant. 
Miscarriage late in pregnancy is often called abortion, 
with a cut-off of approximately 20 weeks gestation used to 
distinguish between miscarriage and abortion.
19.    Early Pregnancy Loss: This usually refers to the loss of 
an embryo very early in pregnancy, even before a clinical 
diagnosis is made, when a woman would not be aware of 
the pregnancy. Such losses are also called occult, because 
they are hidden, or biochemical, because they can only be 
identified by detecting hCG. Pregnancy loss shortly after a 
clinical diagnosis may also be described as early.
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length increased by 10% (from 28 days to 31 days38), the 
estimate for embryo loss drops to 22%. The opposite opera-
tion (e.g., coital frequency increased to 2.5/week) results in 
an estimate of 92% (Table 1). Embryo loss of 22% is barely 
sufficient to account for observed clinical losses, and 92% 
indicates a maximum FEC
LB
 of 8%. Neither scenario is bio-
logically plausible.
2.    A non-zero variance was applied to each speculative 
value reflecting their uncertain nature. Using the random 
number generator in Microsoft® Excel (Office 2010) 
simulated values were obtained by random sampling 
from normal distributions with means equal to Roberts & 
Lowe’s speculative values with coefficients of variation 
equal to 20%. For simplicity, it was assumed that there 
was no covariance between the different speculative val-
ues. Table 1 shows the expected range within which 95% 
of these simulated values fall (e.g., coital frequency is 
1.2–2.8/week). For each simulated record, a new estimate of 
embryo loss was calculated, and from 10,000 of these, the 
mean, median and 2.5th and 97.5th percentiles of embryo 
loss were determined. This step was repeated 1,000 times: 
the mean value of the simulated means was 73.3% and of 
the simulated medians was 76.5%. The mean values of the 
2.5th and 97.5th percentile boundaries for embryo loss 
were 37% and 90% (Table 1). Separately, the same simu-
lation was performed using NONMEM 7.3.0® (Icon PLC, 
Dublin, Eire) to generate 100,000 data records which are 
represented in Figure 2. The code and simulated data values 
are in Dataset 1.
Figure 1. Schematic representation of timelines and key events in (A) non-fecund and (B) fecund menstrual cycles. Menstrual cycle 
lengths vary considerably and most fall within a range of 20 to 40 days45. A typical menstrual cycle is usually represented as lasting for 
28 days, as shown here. Differences in cycle length are mostly due to variations in the duration of the follicular phase, the time from the onset 
of menstruation to ovulation. The time from ovulation to the onset of the next cycle, the luteal phase, is more consistently 14 days. Therefore, 
in the typical 28 day cycle, ovulation occurs midway at around 14 days. The fertile period (shown in light blue) is the time during which coitus 
may result in a pregnancy. The probability of pregnancy is highest when coitus occurs in the two days leading up to ovulation40. In a normal 
fecund cycle, fertilisation occurs within hours of ovulation in the fallopian tube, after which point an embryo is present and development 
begins. Embryonic development may fail at any stage from fertilisation through to birth. 6–7 days after fertilisation, the embryo begins to 
implant in the uterine wall at which stage human chorionic gonadotrophin (hCG) produced by the embryo becomes detectable in urine 
or serum samples. The onset and duration of pregnancy may be defined in various ways: gestational pregnancy (typically used in clinical 
practice) is timed from the first day of the last menstrual period; developmental pregnancy begins with fertilisation; in an IVF treatment cycle, 
although an embryo is present in the uterus immediately following embryo transfer, pregnancy is not considered to be established until there 
is evidence of implantation, usually provided by elevated hCG levels. The earliest point at which a woman could observe that she is pregnant 
is approximately 14 days after ovulation/fertilisation with the first missed period. The stage at which pregnancies are clinically confirmed 
depends on study design and clinical practice, and may be at gestational day 28 (i.e., first missed menstrual period, Zinaman (1996)46, 
French & Bierman (1962)47), gestational day 42 (Wang (2003)48), or following a positive pregnancy test (Wilcox (1988)49) or satisfactory 
ultrasound scan.
Page 5 of 42
F1000Research 2017, 5:2765 Last updated: 12 JUN 2017
Dataset 1. Figure 2 data
http://dx.doi.org/10.5256/f1000research.8937.d140569
See README.docx for a description of the file.
The sole purpose of these simple sensitivity analyses is to illus-
trate that modest adjustments to Roberts & Lowe’s original specu-
lative values can result in any biologically plausible estimate for 
embryo loss. Whilst their analysis is useful for highlighting factors 
that influence observed fecundity, the output from the calculation 
remains substantially dependent on the subjectively selected input. 
Consequently, their analysis has no practical quantitative value.
Other sources of bias in their model include the failure to 
account for intentionally terminated pregnancies and the reduced 
fecundability of already pregnant women and nursing mothers. 
Despite this, it was described as “persuasive”50 and it has been 
claimed that “it is still difficult to better the original calculations 
of Roberts and Lowe (1975)”27. By contrast, others have noted 
that “their calculations can be criticized”9 and are “tenuous”51. 
Considering its quantitative limitations, it has been cited surpris-
ingly often13,28,52,53.
2. Life tables of intrauterine mortality
Constructing a life table of intrauterine mortality is challenging 
since embryonic death may occur even before the presence of an 
embryo is recognised. Nevertheless, in 1977, the distinguished 
demographer Henri Leridon published an impressive critique 
and analysis of pregnancy loss data, and a complete life table of 
intrauterine mortality26. Leridon highlighted the consequences of 
inappropriate analysis and the quantitative biases produced by 
Table 1. Numerical estimates of conceptions and their loss in married women aged 20–29 in England and Wales 
in 1971. The table replicates the values and calculations of Roberts & Lowe34 with more explanatory detail. In addition, it 
illustrates how introducing variance into speculative estimates influences the final calculated value of embryo loss. *Data 
type indicates whether the numerical value is reliable (e.g., derived from census data), the result of a simple arithmetical 
calculation, or speculative (shown in italics). §Values are the 2.5th and 97.5th percentile boundaries, assuming a normal 
distribution for the variables centred on Roberts & Lowe’s values with a coefficient of variation of 20%. †Speculative 
values were adjusted either up or down by 25% compared to Roberts & Lowe’s values. Values for ‘Length of menstrual 
cycle’ were adjusted by 10%. ‡The mean values of the 2.5th and 97.5th percentile boundaries from 1,000 simulations, 
each containing 10,000 separate estimates for embryo loss. The derivation of these values is described in the text. 
Briefly, each separate estimate of embryo loss was calculated using variable speculative values that were obtained by 
random sampling from a normal distribution with a mean equal to the Roberts & Lowe value and a coefficient of variation 
of 20%. The mean value of the mean percentage loss was 73.3% and of the median was 76.5%. ¥The most frequent 
duration of a menstrual cycle is 28 days but there is substantial variability and the mean length is generally 30–31 days38.





95% data range 
(CV = 20%)§
Married women aged 20–29 
in 1971 Reliable value 2,437,000 2,437,000 2,437,000 -
Frequency of coitus per 
married woman per week
Speculative 
value 2 1.5 2.5 [1.2, 2.8]
Weeks per year Reliable value 52 52 52 -
Acts of coitus among 
married women per year Calculation 253,448,000 190,086,000 316,810,000 -
Percentage of acts of coitus 
that are unprotected
Speculative 
value 25% 19% 31% [15%, 35%]
Acts of unprotected coitus 
per year Calculation 63,362,000 35,641,125 99,003,125 -




¥ 25 [17, 39]
Length of fertile period in 
each cycle (days)
Speculative 
value 2 1.5 2.5 [1.2, 2.8]
Acts of unprotected coitus 
during fertile period per year Calculation 4,525,857 1,735,769 9,821,739
Probability of fertilisation Speculative value 50% 38% 63% [30%, 70%]
Total fertilised ova per year Calculation 2,262,929 650,913 6,138,587 -
Number of infants born (live 
and still) in 1971 Reliable value 505,000 505,000 505,000 -
Total number of lost embryos 
in 1971 Calculation 1,757,929 145,913 5,633,587 -
Percentage of embryos 
lost before live birth Calculation 78% 22% 92% [37%, 90%]
‡
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Figure 2. Distribution of embryo loss estimates from fertilisation to birth derived using a modified version of the model of Roberts & 
Lowe34. Embryo loss values were calculated using alternative speculative values (see text and Table 1) obtained by randomly sampling from 
normal distributions with means equal to the Roberts & Lowe values and a coefficient of variation of 20%. 100,000 simulated embryo loss 
values were obtained. Frequencies within a bin size of 0.25% are shown. The 2.5th and 97.5th percentiles are indicated. The simulation was 
performed using NONMEM 7.3.0® (Icon PLC, Dublin, Eire). Simulated values are in Dataset 1.
alternative numerical methods. Overall, he discussed sixteen stud-
ies, and provided detailed commentary on six published between 
1962 and 197047,54–58. These data are summarised in Figure 3 
and suggest that 12–24% embryos alive at 4 weeks’ gestation 
(i.e., approx. 2 weeks’ post-fertilisation, see Figure 1) will perish 
before birth.
Dataset 2. Figure 3 data
http://dx.doi.org/10.5256/f1000research.8937.d140570
See README.docx for a description of the file.
Leridon described the Kauai Pregnancy Study published by 
French & Bierman (1962)47 in particular detail. In this study, an 
attempt was made to identify every pregnancy on Kauai from 
1953–56. Women were encouraged to enrol as soon as they missed 
a period. Pregnancy loss may therefore have been overestimated, 
since not all amenorrhoea is caused by conception, although 
other studies that relied upon medically-identified pregnancies 
probably underestimated pregnancy loss by not capturing all 
cases16. Whatever the truth, it is clear that, among the studies 
reviewed by Leridon, the Kauai Pregnancy Study revealed the 
highest levels of pregnancy loss (Figure 3).
All recorded pregnancies in the Kauai study were categorised by 
date of enrolment in four week intervals, beginning with 4–7 weeks’ 
gestation. This time-staggered approach enabled risk of miscarriage 
to be associated with stage of gestation. However, despite consid-
erable efforts, only 19% of the 3,197 recorded Kauai pregnancies 
were enrolled between 4–7 weeks’ gestation, thereby reducing the 
precision of pregnancy loss estimates for this earliest of time inter-
vals. Although pregnancies were grouped in four week periods, 
Leridon suggested that early mortality may change week by week, 
Figure 3. Graphical representation of the fate of 1,000 
pregnancies in progress at 4 weeks’ gestation (2 weeks’ post-
fertilisation). The figure is generated using values in Table 4.3 of 
Leridon (1977)26 and are derived from six different studies (see text). 
The Kauai Pregnancy Study data published by French & Bierman 
(1962)47 are shown in thick black. Data from Shapiro (1970)57 were 
analysed either with all pregnancies included (ALL) or with those 
pregnancies excluded that aborted within one week of study entry 
(EXCL.). The greater loss observed with ALL may be due to a 
correlation between study entry and abortion risk. Based on these 
data, the risk of losing a pregnancy ongoing at 4 weeks’ gestation 
ranges from 12.5% to 23.7% (excluding Shapiro (1970) ALL). Values 
are in Dataset 2.
resulting in underestimation of pregnancy loss. He re-allocated 
the 592 study entries and 32 pregnancy losses for weeks 4–7 
(Table 2) generating an overall probability of pregnancy loss dur-
ing this period of 15.0%, higher than 10.8% originally reported47. 
Leridon’s own description of this interpolation as “risky” can be 
illustrated by adjusting his re-allocation26. Transferring just two 
of the pregnancy losses out of or into the first week results in 
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Table 2. A speculative numerical re-allocation of entries and pregnancy losses during weeks 4–7 in the Kauai 
Pregnancy Study (KPS)47. Minor differences in the re-allocation of the earliest pregnancy losses have a substantial effect on 
the overall measure of pregnancy loss for that period. (Adapted from Table 4.2 in Leridon26.)
Time period 
of gestation
New entries into study 
in each time period
Actual pregnancy losses 
in each time period
% pregnancy loss in 
each time period
Surviving pregnancies 























5–6 120 6 [6, 6] 4.3 [4.3, 4.4] 95 [100, 90]
6–7 180 10 [11, 9] 3.5 [3.9, 3.2] 91 [96, 86]
7–8 212 14 [15, 13] 3.0 [3.2, 2.8] 88 [92, 83]
4–8 85 [89, 81] 89.2
% loss 15.0 [10.9, 19.1] 10.8
respectively (Table 2). The validity of adjusting Leridon’s re-alloca-
tion may be questioned. However, pregnancy loss in week 4–5 of the 
Kauai Study would manifest as a menstrual period delayed by 
up to one week. This is far from being a robust pregnancy diag-
nosis and in a different study57, exclusion of pregnancy losses 
reported within one week of study entry resulted in substantially 
different loss probabilities (Figure 3) suggesting a confound-
ing correlation between entry and loss26. Nevertheless, the re- 
allocation does reinforce a concern highlighted by Leridon, 
namely the uncertainty that affects the first probability. Clearly, 
these estimates of early loss should be treated with caution.
A more fundamental problem is that these data offer no insight 
into the fate of embryos prior to the earliest possible point of 
clinical pregnancy detection. Leridon completed his life table 
with values from Hertig’s 1967 analysis5. He concluded that 
among 100 ova exposed to the risk of fertilisation, 16 are not 
fertilised, 15 die in week one (between fertilisation and implan-
tation), and 27 die in week two (between implantation and the 
time of the first missed period). After two weeks his life table 
follows the Kauai probabilities closely ending with 31 live 
births. Leridon’s table therefore indicates an embryo mortality of 
50% (42/84) within the first two weeks after fertilisation and a 
total mortality of 63% (53/84) from fertilisation to birth.
Leridon’s account of intrauterine mortality has been widely 
cited. However, its accuracy depends entirely on the quality and 
interpretation of the data from Hertig5 and French & Bierman47. 
French & Bierman’s approach probably resulted in an overes-
timate of total pregnancy loss and is certainly imprecise in its 
estimate of embryo loss in the four weeks following the first 
missed menstrual period. The reliability of Hertig’s estimates of 
embryo loss in the two weeks following fertilisation is considered 
below.
3. Biochemical detection of pregnancy using hCG
Quantification of pregnancy loss requires pregnancy diagnosis. 
The earliest outward sign of pregnancy is a missed menstrual 
period, approximately 2 weeks after fertilisation, although 
amenorrhoea in women of reproductive age is not exclusively 
associated with fertilisation59,60. Several potentially diagnostic 
pregnancy-associated proteins have been identified61 of which 
only one, Early Pregnancy Factor (EPF)62, has been claimed to be 
produced by embryos within one day of fertilisation. However, there 
is doubt about the utility of EPF for diagnosing early pregnancy63 
and little has been published on it in the past five years.
Modern pregnancy tests detect human chorionic gonadotrophin 
(hCG), a highly glycosylated 37 kDa protein hormone produced 
by embryonic trophoblast cells64. Elevation of hCG around 6–7 
days after ovulation is associated with embryo implantation27,28,65 
(Figure 1). Early assays for the detection of hCG were prob-
ably confounded by antibody cross-reactivity with luteinizing 
hormone66 but modern tests are more specific and a positive 
result is a reliable indicator of early pregnancy. Highly sensitive 
assays have revealed low levels of hCG in non-pregnant women 
and healthy men67; hence, quantitative criteria and appropriate 
design are required to distinguish between non-pregnant women 
and those harbouring early embryos65,68,69.
Figure 4 and Table 3 summarise findings from thirteen studies 
that used hCG to identify so-called early, occult or biochemi-
cal pregnancy loss, i.e., pregnancy loss between the initiation of 
implantation and clinical recognition46,48,49,70–79. (Ellish et al. 
(1996)69 is not included since the hCG assay was positive for only 
72.5% of clinical pregnancies. By contrast, among the thirteen 
studies in Table 3 only one clinically-recognised pregnancy was 
reported undetected by hCG testing70. Nevertheless, their 
estimates of early pregnancy loss (17.4%) and clinical loss (13.7%) 
are comparable to these other studies.) Each study measured uri-
nary hCG levels except two, which measured hCG in serum72,73. 
Notwithstanding design and subject differences, estimates for clin-
ical pregnancy loss, ranging from 8.3% – 21.2% (Figure 4), are 
similar to previous estimates (Figure 3). Estimates for early/occult 
pregnancy loss ranged from 0% to 58.3% in studies70–74 prior to 
Wilcox (1988)49. This high variance was probably due to reduced 
specificity and sensitivity of the hCG assays and sub-optimal 
study design16,61,80–83. Studies from Wilcox (1988)49 onwards have 
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Figure 4. Summary of findings from thirteen studies that used hCG detection to diagnose early pregnancy. Data are arranged by 
publication date and the first author of the study is shown. Three datasets are shown: (i) the percentage of at risk menstrual cycles that 
were hCG positive; (ii) the percentage of hCG positive cycles that did not manifest as clinical pregnancies = early pregnancy loss; and 
(iii) the percentage of clinical pregnancies lost prior to 12 or 28 weeks or live birth (definitions vary between studies). A clinical pregnancy 
may be manifest by a missed period although criteria vary between studies. Videla-Rivero et al.73, Sasaki et al.76, Cole78 and Mumford 
et al.79 do not report sufficient data to calculate all three values. Values are in Dataset 3.
Table 3. Summary data from thirteen studies using hCG detection to diagnose pregnancy and identify early pregnancy 
loss. Raw FECHCG is the ratio of hCG pregnancies detected and the number of cycles monitored in each study. Where 
available, mean (SD) ages of the participating women are taken directly from the published study. In some cases mean and 
SD (indicated by *) or SD (indicated by †) were estimated based on published demographic characteristics. §These data relate 
to the whole study cohort (n=124) which included known sub-fertile women, and not just to the 74 apparently fertile women. 
‡Mean value from Wilcox et al. (2001)84. ¶Some studies only provide data up to late pregnancy (e.g., up to 28 weeks) rather 
than to term. ND = no data. ¤Wilcox subsequently reported an additional hCG pregnancy which had not been detected and 
reported in the 1988 paper, making a total of 199 hCG pregnancies and 44 pre-clinical losses in the study group85. #Mumford 
reported data from aspirin- and placebo-treated subjects who had at least one prior miscarriage. Summary data from both 



























Miller 1980 197 27 (4)* 623 152 24.4% 102 67.1% 42.4%
Edmonds 1982 82 27 (4)* 198 118 59.6% 51 43.2% 61.9%
Whittaker 1983 91 30 (3.7)† 226 92 40.7% 85 92.4% 19.6%
Videla-
Rivero 1987 27 ND 27 12 44.4% 5 41.7% ND
Walker 1988 38 27.4 [22–38] 75 25 33.3% 25 100% 16.0%
Wilcox 1988 221 30‡ (4)* 707 198¤ 28.0% 155 78.3% 31.3%
Hakim 1995 74 31 (3)*§ 305 66 21.6% 52 78.8% 37.9%
Zinaman 1996 200 30.6 (3.3) 432 116 26.9% 101 87.1% 31.3%
Wang 2003 518 24.9 (1.7) 1,561 618 39.6% 466 75.4% 35.7%
Sasaki 2008 110 [21–36] ND 62 ND 50 80.6% 32.3%
Koot 2011 46 28.7 (3.3) 103 30 29.1% 24 80.0% 26.7%
Cole 2012 168 28.8 (4.4) ND 127 ND 99 78.0% 36.2%
Mumford 2016 1088# 28.7 (4.8) ND 785 ND 730 93.0% 23.9%
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produced more consistent data indicating early/occult pregnancy 
loss of approximately 20% (Figure 4). In the largest studies48,79 
pregnancies were clinically recognised only if they lasted ≥6 weeks 
after the onset of the last menstrual period; hence, early pregnancy 
losses in these studies included those lost up to approximately 
two weeks after a missed menstrual period. Definition of clinical 
pregnancies can influence comparison of study results39,82. 
For example, Wilcox originally reported 43 (later 4485) pre- 
clinical and 19 clinical losses from 198 detected pregnancies49, 
giving 21.7% early/occult and 12.3% clinical loss rates. In later 
reports, 4 cases were re-allocated resulting in 48 early and 15 
clinical losses (i.e., 24.1% early/occult and 9.9% clinical 
loss rates)40,86–88. Variable definitions can generate confusion, 
although in this case the overall picture is not greatly affected. 
Based on the eight most recent studies, beginning with Wilcox 
(1988), pregnancy loss from first detection of hCG through to 
live birth is approximately one third (Table 3). This is consistent 
with another recent study which found that 98 out of 301 (32.6%) 
singleton pregnancies diagnosed by an early positive hCG test 
and followed-up to either birth or miscarriage were lost89.
Dataset 3. Figure 4 data
http://dx.doi.org/10.5256/f1000research.8937.d140571
See README.docx for a description of the file.
The much cited Wilcox (1988) study49 is the earliest of several 
large well-designed studies that made use of a specific and sensitive 
hCG assay and led to numerous further publications40,84–87,90–92. 
Two other studies (Zinaman (1996)46 and Wang (2003)48) were 
similar in purpose, design and execution. These studies pro-
vide some of the best available data to calculate pregnancy loss 
between implantation and birth39. In each study, women intend-
ing to become pregnant and with no known fertility problems 
were recruited and hCG levels monitored cycle by cycle in daily 
urine samples until they became pregnant. Most women were fol-
lowed through to late pregnancy or birth. Although these studies 
provide evidence regarding the outcome of both clinical and hCG 
pregnancies, determining the fate of embryos prior to implanta-
tion is more difficult. To relate the study results to pre-implantation 
embryo loss, it is necessary to determine fecundability. In 
each study FEC
CLIN
 declined in successive cycles as the pro-
portion of sub-fertile women increased. Hence, reported raw 
FEC
HCG
 values of 30%46 and 40%48, and FEC
CLIN
 values of 25%49 
and 30%48 are biased underestimates of the fecundability of 
normal fertile women. A recent re-analysis of these data 
provides statistical evidence for discrete fertile and sub-fertile 
sub-cohorts within the study populations39. The proportions of 
sub-fertile women (mean [95% CI]) were estimated as 28.1% 
[20.6, 36.9] (Wilcox); 22.8% [12.9, 37.2] (Zinaman); and 6.0% 
[2.8, 12.3] (Wang). For normally fertile women, FEC
HCG
 was, 
respectively: 43.2% [35.6, 51.1]; 38.1% [32.7, 43.7]; and 46.2% 
[42.8, 49.6]. FEC
CLIN
 was: 33.9% [29.4, 38.6]; 33.3% [27.6, 39.6]; 
and 34.9% [33.0, 36.8]. There was no apparent difference in 
π
CLIN
 between fertile and sub-fertile sub-cohorts, which was 
estimated as: 78.3% [69.2, 85.3]; 87.5% [76.0, 93.9]; and 75.4% 
[71.5, 79.0]39.
Why do a proportion of menstrual cycles in women attempting to 









 , there can be various causes for this failure includ-
ing mistimed coitus, anovulation, failure of fertilisation or pre- 
implantation embryo death. Although FEC
HCG
 puts limits on the 







 translates into uncertainty in estimates of 
pre-implantation embryo mortality. In the Wang study, for normally 
fertile women, FEC
HCG
 = 46.2%; hence, the absolute maximum 





 = 1, conditions both extreme and unlikely39. 
Studies of the relationship between coital frequency and concep-
tion indicate that fecundability is greater with daily compared to 
alternate day intercourse39,93,94. Hence, when coital frequency is less 
than once per day a proportion of reproductive failure will be due to 
mistimed coitus, i.e., π
SOC
 < 1. In the Wilcox study, coitus occurred 
on only 40% of the six pre-ovulatory days39,40, and in the Zinaman 
study participants were advised that alternate day intercourse was 
optimal46. Based on the difference in fecundability between daily 
and alternate day intercourse as modelled by Schwartz94, a value 
of π
SOC
 = 0.80 was used to calculate pre-implantation embryo 
mortality39. However, this is a speculative estimate, and in reality 
the value may be higher, or lower.
A further critical missing piece of the equation is knowledge of the 
efficiencies of fertilisation and implantation under normal, natural, 
propitious circumstances. Assuming that either of these processes 
may be up to 90% efficient, and based on data from the three hCG 
studies46,48,49, a plausible range for pre-implantation embryo loss in 
normally fertile women is 10–40% and for loss from fertilisation 
to birth, 40–60%39. Even with these wide ranges of mathematically 
possible outcomes, it is clear that estimates for total embryonic loss 
of 90%37, 85%36, 83%2, 80–85%11,35, 78%34, 76%10,33 and 70%27–31 
are excessive.
In 1990, Charles Boklage concluded that “at least 73% of natu-
ral single conceptions have no real chance of surviving 6 weeks 
of gestation”10,95. Live birth fecundability was estimated as “not 
over 15%”, substantially lower than Leridon’s 31%. Despite this 
discrepancy, Boklage’s conclusions were derived from a review of 
data including several hCG studies49,65,70–73 and Leridon’s analysis26. 
He derived a model describing the survival probability of human 
embryos comprising the sum of two exponential functions:
Pt(pregnancy survival) = 0.73e-0.155t + 0.27e-0.00042t
in which t is the time in days post-fertilization. This is the source of 
the 73% in the conclusion.
There are, however, serious problems with this analysis. Firstly, 
data presented as embryo survival probabilities at different times 
post-fertilization49,65,70,71,73 are fecundabilities, i.e., successes per 
cycle, not per fertilised embryo. Secondly, for reasons that are 
unclear, data from Whittaker72 and Leridon26 were excluded 
from the modelling analysis and the data from an earlier Wilcox 
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report65 were included twice since this preliminary data had been 
incorporated into the later report49. Thirdly, the modelled data 
were normalised to a survival probability of 0.287 at 21 days 
post-fertilization. This value was derived from data published by 
Barrett & Marshall (1969) on the relationship between coital fre-
quency and conception93. Barrett & Marshall had concluded that 
coitus during a single day alone, 2 days before ovulation, resulted in 
a conception probability of 0.30. Boklage’s value of 0.287 is his cal-
culated equivalent. However, conception in this study was “identi-
fied by the absence of menstruation, after ovulation”93. Hence, 0.30 
(and similarly, 0.287) is a clinical fecundability and not a measure 
of embryo survival. Furthermore, 0.30 is a non-maximal fecund-
ability, since it was an estimate based on coitus on a single day 
(2 days before ovulation) within the cycle. Barrett & Mar-
shall clearly report that as coital frequency increased so did the 
fecundability, up to a maximum of 0.68 associated with daily 
coitus93.
Boklage’s analysis can only make biological sense if it is assumed 
that every cycle in the Barrett & Marshall study resulted in fer-
tilisation. Under these circumstances, failure to detect conception 
in 71.3% (1 – 0.287) of cycles would be due entirely to embryo 
mortality. However, this is highly implausible and explicitly 
contradicted by the higher estimate of fecundability reported93. 
Boklage’s implicit assumption also contradicts his further conclu-
sion that “only 60–70% of all oocytes are successfully fertilized 
given optimum timing of natural insemination”10. The vertical nor-
malisation of the hCG study data to a value of 0.287 at 21 days is the 
principal determinant of the parameters that define the two exponen-
tial model. Any change in this value would commensurately alter 
the balance between the two implied sub-populations of embryos. 
Since it is evident that the value of 0.287 is neither an embryo sur-
vival rate nor even a maximal fecundability, it follows that quan-
titative conclusions from this analysis in relation to the survival of 
naturally conceived human embryos are of doubtful validity.
However, Boklage was right about two things. Firstly, the difficulty 
of calculating pre-clinical losses: as he put it, “In the place of the 
necessary numbers for the first few weeks of pregnancy we find 
editorially acceptable estimates which, while perhaps not far 
wrong, are difficult to defend with any precision”. Secondly, the 
source of some of the only directly relevant data (even though he 
excluded it from his modelling analysis), namely, “Hertig’s sample 
is, and will probably remain, unique”.
4. The anatomical studies of Dr Arthur Hertig
At the start of the 1930s, no-one had ever seen a newly fertilised 
human embryo. It was barely 60 years since Oscar Hertwig had 
first observed fertilisation in sea urchins96, and just 40 years before 
the birth in 1978 of Louise Brown, the first test tube baby97,98. In 
Boston, Dr Arthur Hertig and Dr John Rock’s search for early human 
embryos generated an irreplaceable collection, and set an influential 
benchmark for the scale of early human embryo mortality.
The so-called “Boston Egg Hunt” began in 193899. Hertig and Rock 
recruited 210 married women of proven fertility who presented 
for gynaecological surgery44. (In most of their publications, the 
number is given as 2105,100,101 although 211 subjects are mentioned 
elsewhere44.) Of these, 107 were considered optimal for finding 
an embryo because they apparently: (i) demonstrated ovulation; 
(ii) had at least one recorded coital date within 24 hours before 
or after the estimated time of ovulation; (iii) lacked pathologic 
conditions that would interfere with conception. Hertig examined 
the excised uteri and fallopian tubes, and over fifteen years found 
34 human embryos aged up to 17 days5,44,100–107. Of these, 24 were 
normal and 10 abnormal5,100. (There is some confusion over this: 
in three publications44,101,107, 21 embryos are described as normal 
and 13 as abnormal. It appears that the three alternatively described 
embryos (C-8299; C-8000; C-8290) were originally defined as 
abnormal based on their position or depth of implantation44.) 
Table 4 provides information about the 34 embryos found in these 
107 women. Although the study was primarily intended to find 
and describe early human embryos, Hertig subsequently used 
the data to derive estimates of reproductive efficiency including 
early embryo wastage5,100.
Hertig’s analysis5,100 relies heavily on the 15 normal and 6 abnormal 
implanted embryos found in 36 women from cycle day 25 onwards. 
Table 4. Summary of the characteristics of Hertig’s 34 embryos (values are taken from Figure 4 in Hertig et al. (1959))100.  
The embryos were collected from 107 out of 210 women. *In Hertig’s figure, day 28 of the ovulatory cycle is identified with 
day 1 of the next cycle and is the day of the presumed missed period in cases where pregnancy had commenced. The 


















14 Ovulation ± fertilisation 0 0 0 0 0
16–17 Embryo suspended in fallopian tube 2–3 9 1 1 0 11.1%
18–19 Embryo suspended in uterus 4–5 15 7 3 4 46.7%
20–24 Implantation 6–10 47 5 5 0 10.6%
25–3 First missed period on day 28/1* 11–16 36 21 15 6 58.3%
Total 107 34 24 10 31.8%
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He assumed the 6 abnormal embryos would perish around the time 
of the first period concluding that fertility (% pregnant) at this stage 
= 42% (15/36). Of the 8 pre-implantation embryos identified (7 in 
the uterus and 1 in the fallopian tubes), 4 were abnormal. Hertig 
assumed the 4 normal embryos would implant successfully but that 
some of the abnormal ones would not, such that the proportion of 
normal embryos would increase from 50% (4/8) before implantation 
to 71% (15/21) after implantation as observed. Hence, among the 
36 post-cycle day 25 cases, in addition to the 15 normal embryos, 
there must have been 15 abnormal pre-implantation embryos of 
which 60% (9/15) failed to implant and were not observed, and 
40% (6/15) did implant and were observed, although these 6 would 
have perished shortly afterwards. This left 6/36 eggs that must have 
been unfertilised. The ratio of ‘unfertilised’: ‘fertilised abnormal’: 
‘fertilised normal’ was therefore 6:15:15, matching the 16% infer-
tility (no fertilisation), 42% sterility (post-fertilisation death) and 
42% fertility (reproductive success) reported in Figure 9 of Hertig’s 
1967 article, “The Overall Problem in Man”5. This is the source 
of Hertig’s 84% fertilisation rate and 50% embryo loss before and 
during implantation, and is reproduced in Leridon’s life table26 as 
84/100 eggs surviving at time zero (ovulation and fertilisation) and 
42 surviving to 2 weeks (time of first missed period).
Hertig provides almost the entire body of evidence used to quantify 
natural human embryo loss in the first week post-fertilisation. Most 
claims regarding early human embryo mortality find their source 
here. Before considering how reliable the figures are, it is worth 
repeating Hertig’s own caveat, namely, the lack of data on the effi-
ciency of natural fertilisation5. All estimates of embryo mortality 
from fertilisation onwards are subject to commensurate inaccuracy 
in the absence of reliable fertilisation probabilities (i.e., π
FERT
), 
which are “surprisingly difficult to estimate”21.
There are several problems with Hertig’s analysis. As noted by 
others, the observations are cross-sectional, but the inferences are 
longitudinal108. Hertig detected 21 embryos from 36 cases (58.3%) 
from cycle day 25 onwards. If this detection rate were represent-
ative, then on average, prior to day 25, the detection rate should 
either be the same or higher; however, they are all lower, and sub-
stantially so (Table 4). Hertig suggested that this was due to the 
technical difficulty of finding newly fertilised embryos. 
However, the detection rate for cycle days 18–19 was good 
(46.7%) and embryos one or two days younger would not have 
been much smaller, at which stage the detection rate was poor 
(11.1%). An alternative explanation for this discrepancy might sim-
ply be random variation. Furthermore, from cycle day 25 onwards, 
embryos would probably have produced hCG and therefore 
FEC
HCG
 would have been at least 58%. This is approximately dou-
ble the equivalent values observed in more recent and robust hCG 
studies (Table 3) further suggesting that this subset of the data is 
not representative.
Despite having proven fertility, these women presented 
for gynaecological surgery which, according to Hertig, was “medi-
cally essential”99. This suggests that the women may have had sub-
optimal reproductive function, although the effect of this on the 
quantitative outcome of the study is difficult to gauge. Furthermore, 
Hertig’s reproductively ‘optimal’ coital pattern does not include 
2 days pre-ovulation and does include one day post-ovulation, con-
ditions which are known not to maximise fertilisation39,40,93,94,109. 
Hence, detection rates before cycle day 25 may be more representa-
tive than those after. Given the numerical discrepancies, they cannot 
both be.
Hertig does not provide error estimates with his conclusions. In 
order to estimate the precision of his derived proportions, a boot-
strap analysis was performed as follows: Hertig’s 107 optimal cases 
were categorised according to stage of cycle (Category 1 = cycle 
days 16–19 (n=24); Category 2 = cycle days 20–24 (n=47); Cate-
gory 3 = cycle days ≥25 (n=36)), and presence and type of embryos 
(Category 0 = no embryo (n=73); Category 1 = normal embryo 
(n=24); Category 3 = abnormal embryo (n=10)). Five hundred 
pseudo-datasets each containing 107 cases were generated using a 
balanced random re-sampling method using Microsoft Excel®. The 
original and pseudo datasets are in Dataset 4.
Dataset 4. Pseudo-datasets of Hertig’s study, obtained via a 
bootstrap procedure
http://dx.doi.org/10.5256/f1000research.8937.d140572
See README.docx for a description of the files.
Hertig’s numerical calculations, as detailed above, were repeated 
for each pseudo-dataset thereby generating 500 estimates for each 
parameter, from which were derived median values and [95% 
CIs] using the percentile method110: fertility = 42% [26%, 59%]; 
sterility = 42% [5%, 182%]; infertility = 16% [-127%, 61%]; pre-
implantation embryo survival probability = 69% [27%, 128%]; 
post-implantation to week two survival probability = 71% [50%, 
91%]; detection rate for cycle day 25 onwards = 58% [41%, 74%]. 
Median values matched estimates calculated from the original data-
set. Bootstrap 95% CIs for the day 25 detection rate (58%) matched 
those calculated using the “exact” method of Clopper & Pearson111, 
[41%, 74%], which are a little wider than those calculated using the 
“more exact” method of Agresti & Coull112, [42%, 73%]. (These 
analyses were performed using an online GraphPad® calculator 
accessed on 18th April 2017: http://www.graphpad.com/quickcalcs/
ConfInterval1.cfm.) The congruence between these confidence 
intervals and the point estimates provides some reassurance that that 
the bootstrap procedure worked effectively. Estimates of parameters 
other than the day 25 detection rate (58%) are derived from more 
complex proportional relationships, and are therefore less precise. 
Table 5 reproduces a life table in the style of Leridon26 and includes 
probabilities for each reproductive step with confidence inter-
vals. These intervals (and some noted above) are impossibly wide 
highlighting further problems with Hertig’s analysis.
Hertig’s analysis omits 47 cases from cycle days 20–24, com-
prising 44% of his data. It is clear why he cannot use it, since all 
five embryos were normal and, given his mathematical and bio-
logical assumptions, five normal implanting embryos could not 
become 29% (6/21) abnormal post-implantation. Others have 
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also noted that these “missing data are sufficient to engender an 
entirely different result”16. Furthermore, the data that define the 
50% proportion of abnormal pre-implantation embryos (i.e., 4/8) 
are so few that any numerical variation will make a substantial 
difference to derived proportions. If he had observed 3/8 abnor-
mal embryos, his estimate of pre-implantation loss would have 
been 13% rather than 30%: for 5/8 it would have been 48%, 
with a fertilisation rate of 111%, which is clearly impossible. 
It seems therefore, that Hertig designed his analysis based on a 
post-hoc examination and selective use of the data. His own caveat 
about the lack of relevant and necessary data should be taken at 
least as seriously as his conclusions.
Hertig and Rock’s contribution to human embryology is undeniable 
and their quantitative conclusions have profoundly influenced our 
impression of the extent of early human embryo mortality. Regret-
tably, their estimates have a cripplingly low precision, which under-
mines their biological credibility or utility. In conclusion, Hertig’s 
data and flawed analysis cannot be regarded as a reliable quanti-
tative foundation upon which to evaluate and understand natural 
human reproduction.
Discussion
Answering the question “How many fertilised human embryos die 
before or during implantation under natural conditions?” is dif-
ficult. Relevant, credible data are in short supply. Among regularly 
cited publications, the Lancet hypothesis34 is entirely speculative 
and in the view of the current author should cease to be used as an 
authoritative source. Clinical pregnancy studies are only useful for 
quantifying clinical pregnancy loss and contribute nothing to esti-
mates of embryo mortality in the first two weeks’ post-fertilisation. 
Even Hertig’s unique dataset is inadequate to draw quantitative 
conclusions and oft-repeated values should be treated with scepti-
cism. The hCG studies from 1988 onwards provide the best data for 
estimating embryo mortality although a lack of information on fer-
tilisation success rates5,16,21,23,113 prevents satisfactory completion of 
the calculations. A recent re-analysis of these data proposed plausi-
ble limits for reproductively normal women indicating that approxi-
mately 10–40% of embryos perish before implantation and 40–60% 
do so between fertilisation and birth39. However, these ranges are 
wide, particularly for pre-implantation mortality, reflecting the lack 
of appropriate data. Is there any possibility of narrowing down the 
numbers?
In the 1980s, two separate groups collected embryos from women 
following carefully timed artificial insemination as part of fertil-
ity treatment. Insemination around the time of ovulation in women 
of proven fertility was followed 5 days later by uterine lavage to 
recover ova114–117. These data appear to hold promise for determin-
ing fertilisation efficiency and some authors have made quantitative 
inferences about embryo mortality from them24,27,28. However, such 
inferences are complicated by numerous confounding factors. For 
example, in one series116, from 88 uterine lavages following artifi-
cial insemination by donor (AID), 4 unfertilised eggs, 6 fragmented 
eggs, and 27 embryos from 2 cell to blastocyst stage were retrieved. 
In the 51 cycles in which no egg or embryo was retrieved, there was 
one retained pregnancy suggesting that the lavage and ova retrieval 
efficiency was reasonably high, albeit not perfect. These data there-
fore suggest that FEC
TOT
 was low (≈31/88 = 35%) although a pro-
portion of fertilised eggs may have completely degenerated within 
the first 5 days. Assuming π
SOC
 was high (given the targeted insemi-
nation), this suggests that π
FERT
 ≈ 50%. In the context of the recent 
analysis39, this implies that π
HCG
 is high and that levels of embryo 
mortality are therefore towards the lower end of the 10–40% and 
Table 5. Life Table of egg survival and probabilities during the first two weeks of development derived solely from Hertig’s 
data. The table is modelled on Leridon’s life table26 and includes his values for survivors and data from Hertig5. Probabilities are also 
shown for each stage of the early development process. Medians and 95% confidence intervals derived from a bootstrap analysis of 
Hertig’s data indicate the precision in the estimates for fertilisation and embryo loss in the first two weeks. *Although Leridon’s values 
are based on Hertig, they do not fully match. Leridon reports losses of 15 and 27 in the first and second weeks respectively. However, 
Hertig’s 60% loss of abnormal pre-implantation embryos implies 25 (0.6 × 42) losses in the first week leaving 58, and 16 (58 × (6/21)) 
losses in the second week, leaving 42. ¥A value of πSOC = 0.90 was used to avoid the calculation of probabilities greater than 1.
Week after Ovulation Biological Description Survivors (Leridon18) Survivors (Hertig33) Bootstrap Median [95% CIs]
Number of Cycles 100 100 100 [100, 100]
0 Fertilised Eggs 84 83 84 [39, 227]
1 Implanted Embryos 69* 58 58 [41, 74]
2 Missed First Period 42 42 42 [26, 59]
Probabilities Biological Description Probabilities Probabilities
Bootstrap Median 
[95% CIs]
πSOC × πFERT Fertilisation per cycle 0.84 0.83 0.84 [0.39, 2.27]
πFERT (when πSOC = 0.90
¥) Fertilisation per ideal insemination 0.93 0.93 0.93 [0.43, 2.52]
πHCG Fertilised egg implanting 0.82* 0.70 0.69 [0.27, 1.28]
πCLIN Implanted egg to clinical recognition 0.61* 0.71 0.71 [0.50, 0.91]
πHCG × πCLIN Fertilised egg to clinical recognition 0.50 0.50 0.50 [0.20, 0.88]
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40–60% ranges. However, the clinical pregnancy rate following 







 ≈ 75%, as suggested by the hCG studies (Table 3), this 
would mean that π
HCG
 ≈ 50%. This would imply that π
FERT
 is high, 
fertilised egg degeneration is high, occurs before day 5 and was 
therefore unobserved, and hence levels of embryo mortality tend 
towards the upper end of the 10–40% and 40–60% ranges.
It is possible that the lavage/transfer procedure reduced implanta-





. A comparison of AID pregnancy rates may provide some 
insight as suggested by the authors116. The clinical pregnancy rate 
in their pharmacologically unstimulated cohort was 12.5% (11/88) 
which is lower than an equivalent 18.9% observed for fresh semen 
AID118, and also the live birth rate (which also incorporates clinical 
pregnancy losses) of 14.7% reported by the HFEA for AID in 2012 
in unstimulated women aged 18–34119. These different success 
rates suggest that the lavage/transfer procedure did adversely affect 
implantation and early gestation with clear implications for quan-
titative extrapolation. Furthermore, the women who were embryo 
recipients were receiving fertility treatment and their overall fertil-
ity may have been lower than expected in a normal healthy cohort. 
In summary, it seems that there are too many unresolved variables 






With high fecundability, the range of possible embryo mortality 
rates falls. Red deer hinds have pregnancy rates of >85% follow-
ing natural mating120: establishing numerical limits for embryo 
mortality under these efficient reproductive circumstances is more 
straightforward. By contrast, humans lack the instinct to mate 
predominantly during fertile periods thereby reducing observed 
reproductive efficiency substantially. In studies of early pregnancy 
loss, owing to sub-optimal coital frequency and cohorts including 
sub-fertile couples, natural fecundability was almost certainly not 
maximised39. Combining data on coital frequency and hCG ele-
vation may help to address this. In 1995, applying the Schwartz 
model94 to his 1988 hCG data49, Wilcox calculated a FEC
HCG
 value 
of 36% for high coital frequencies (>4 days with intercourse in 6 
pre-ovulatory days)40. However, the Schwartz model assumed that 
cycle viability was evenly distributed among couples, a condition 
which the authors recognised was not true and is contradicted by a 
subsequent analysis which suggests that approximately a quarter of 
the Wilcox cohort was sub-fertile39. If possible, focussing analytical 
attention on normally fertile women with the highest coital frequen-
cies may help to narrow the range of plausible embryo mortality.
In this review of natural early embryo mortality no use has been 
made of data from in vitro fertilisation (IVF) and associated labo-
ratory studies. Sub-optimal conditions for embryo culture mean 
that it was121,122 and probably still is123 doubtful that reliable values 
can be extrapolated from laboratory in vitro to natural in vivo 
circumstances28. Importantly, the reproductive stages are also 
altered. In IVF, π
SOC
 = 1 and for transferred embryos π
FERT
 = 1. Fur-
thermore, transferred embryos are selected based on quality crite-
ria, however inexact those may be123,124. IVF program manipulations 
may reduce π
HCG
 compared to natural circumstances6 and implanta-
tion failure remains a substantial issue for IVF125,126. Although for 
IVF cycles, the reported live birth rate per cycle has gone up (from 
14% in 1991 to 25.4% in 2012119), comparison of IVF success rates 
and natural live birth fecundability values involves too many unde-
fined variables to shed numerical light on early natural embryo 
development and mortality.





 = 1, and successful fertilisation can be observed. 
In seven studies of natural cycle IVF, fertilisation was successful 
in 70.9% (443/625) of attempts127–133. If this represented natural, 
in vivo fertilisation, based on the recent analysis39, it implies that 
π
HCG
 ≈ 0.75, focusing estimates for pre-implantation embryo loss 
on 25%, and for total loss on 50%. However, high frequencies of 
chromosomal aberrations caused by the in vitro handling of human 
oocytes134 can render any comparison of natural and assisted repro-
duction open to criticism9.
In calculating summary values of embryo mortality, it is important 
to note that human fertility is as numerically heterogeneous as it 
could possibly be. Some couples are infertile and some are highly 
fertile. Excessive attention to averages and neglect of variances fos-
ters a misleading appreciation of reality. The hCG studies clearly 
had both fertile and sub-fertile participants: use of overall values 
underestimated fecundability for the fertile majority39. Furthermore, 
apparently ‘optimal’ conditions for conception may not maximise 
human biological fecundability. Other biological factors also con-
tribute to reproductive heterogeneity in humans; however, even after 
controlling for age-related decline, fecundability remains highly 
variable119,135. For intercourse occurring 2 days prior to ovulation, 
average fecundabilities resembled those previously published88, but 
for couples at the 5th and 95th percentiles, fecundabilities were 5% 
and 83%. 83% fecundability implies a very low embryo mortal-
ity rate. In conclusion, apparent low fecundability in humans need 
not necessarily be caused by embryo mortality, but also defects of 
ovulation, mistimed coitus, or fertilisation failure39. Where fecund-
ability is low, any or all of these factors may contribute.
Embryo mortality and pregnancy loss are not only a matter of aca-
demic scientific interest, and diverse quantitative estimates can also 
be found in popular media. For example, 70% loss in the first six 
days is claimed by Michael Mosley in “You made it through the 
first round” (http://www.bbc.co.uk/timelines/z84tsg8; transcript 
at http://a.files.bbci.co.uk/bam/live/content/z3b87hv/transcript: 
accessed on 20th April, 2017). By contrast a 25% pre-implantation 
loss is reported by the Science Museum’s online exhibit, “Who Am 
I?” (http://www.sciencemuseum.org.uk/WhoAmI/FindOutMore/
Yourbody/Wheredidyoucomefrom/Howdoyougrowinthewomb/
Whathappensinweek1): accessed on 20th April, 2017). News reports, 
often associated with ethical controversies, also feature estimates 
of embryo loss. On 1st February 2016, James Gallagher reported 
that only 13/100 fertilised eggs develop beyond 3 months (http://
www.bbc.co.uk/news/health-35459054): accessed on 20th April, 
2017) and on 4th May 2016, Sarah Knapton reported in the online 
Daily Telegraph that “two thirds of pregnancies fail because the 
embryo does not implant properly” (http://www.telegraph.co.uk/
science/2016/05/04/human-embryos-kept-alive-in-lab-for-unprec-
edented-13-days-so-sci/): accessed on 20th April, 2017). In an 
ethical advocacy video, Bill Nye (“The Science Guy”) begins by 
claiming that “Many, many, many, many more hundreds of eggs 
are fertilized than become humans” (https://www.youtube.com/
watch?v=4IPrw0NYkMg): accessed on 20th April, 2017). Addition-
ally, academic philosophical articles1 and legal judgements4 have 
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considered the significance of the scale of embryo loss. Given the 
breadth of societal interest in this facet of human reproductive biol-
ogy, it is vital that scientists report plausible and defensible esti-
mates for natural embryo mortality. Above all, it is obvious that 
women wishing to have children deserve reliable and unbiased esti-
mates of reproductive success and pregnancy failure.
Pregnancy loss and embryo mortality under natural conditions are 
real and substantial. However, estimates of 90%37, 85%36, 80%11,35, 
78%34, 76%10,33 and 70%27–31 total loss are excessive and not sup-
ported by available data. Estimates for clinical pregnancy loss are 
approximately 10–20%. For women of reproductive age, losses 
between implantation and clinical recognition are approximately 
10–25%. Loss from implantation to birth is approximately one 
third39,46,48,49.
Natural pre-implantation embryo loss remains quantitatively 




 it is 
almost impossible to estimate precisely. Hertig’s estimate is 30%; 
however, mathematically and biologically implausible confi-
dence intervals [-28%, 73%] betray the quantitative weaknesses 
in his data and analysis. The best available data for quantify-
ing early pregnancy loss are from studies monitoring daily 
hCG levels in women attempting to conceive. A recent re-analysis39 
of data from three studies46,48,49 concluded that, in normal healthy 
women, 10–40% is a plausible range for pre-implantation 
embryo loss and overall pregnancy loss from fertilisation to 
birth is approximately 40–60%. This latter range is consistent 
with Kline’s estimate of 50%16, and similar to, although a little 
narrower than the 25–70% suggested by Professor Robert 
Edwards136.
In the absence of suitable data to quantify pre-implantation loss, 
many published articles and reviews merely restate previously pub-
lished values11,28,29. It has been suggested that “claimed research 
findings may often be simply accurate measures of the prevailing 
bias”137. Widely held views on early embryo mortality may reflect 
an entrenched and biased view of the biology. For example, the 
Macklon “Black Box” review28 has been cited 212 times (Web of 
ScienceTM citations on 12th April 2017) with many articles explic-
itly referencing its 30% survival/70% failure values13,29,125,138–146. 
Macklon’s quantitative summary in his “Pregnancy Loss Iceberg” 
(30% implantation failure; 30% early pregnancy loss; 10% clinical 
miscarriage; 30% live births) is a direct, unedited reproduc-
tion of estimates published over 10 years previously27. 30% pre-
implantation loss fairly represents Hertig’s conclusions although, 
as has been shown, this estimate is highly imprecise. However, 
Macklon misrepresents the best data which he reviews46,49. Wilcox 
reports early pregnancy loss (i.e., [1 - π
CLIN
]) of 21.7% whereas 
Macklon’s iceberg implies that 43% (30/70) of implanting embryos 
fail before clinical recognition. The iceberg’s clinical loss rate of 
25% (10/40) is also higher than relevant data indicate (Figure 3 





]) is 57% (40/70) according to the iceberg. By contrast, 
Wilcox49 and Zinaman46, both included in Macklon’s review, 
report that only 31% of hCG positive pregnancies fail.
Early pregnancy loss of 10–25% is not trivial. Despite difficul-
ties associated with extrapolating in vitro observations to in vivo 
circumstances, implantation is clearly a crucial biological milestone 
in embryonic development and pregnancy. Recent studies 
suggest that biological mediators from embryos may regulate 
endometrial receptivity resulting in selective implantation of fitter 
embryos18,147,148. Interestingly, supernatant from developmentally 
impaired IVF embryos deemed unsuitable for transfer provoked 
a different response in endometrial cells compared to supernatant 
from developmentally competent embryos that produced an ongo-
ing pregnancy after transfer18. However, it would be of interest to 
compare these responses to that provoked by supernatant from 
developmentally competent embryos that did not successfully 
implant and produce an ongoing pregnancy. Arrested or develop-
mentally impaired embryos may lose cellular integrity and release 
mediators that disrupt endometrial receptivity; however, the intrinsic 
developmental competence of such embryos must also determine 
the success of implantation. Implantation failure is a substantial 
issue for IVF125, and distinguishing between obviously impaired 
and competent embryos is not the principal challenge, but rather 
distinguishing from among apparently competent embryos those 
that will successfully implant and those that will not. Striking 
evidence suggests that only 9% of IVF embryos have a normal 
karyotype in all their cells145,149 raising the possibility that the 
rate of aneuploidy in IVF embryos is artefactually high, or that a 
degree of mosaic aneuploidy in human embryos is not necessar-
ily developmentally deleterious, or indeed both. Implantation 
failure of a normal embryo may well be an uncommon event51, but 
defining what is normal is a considerable scientific and conceptual 
challenge.
If Macklon’s28 (and Chard’s27) 70% estimate for embryo loss is 
excessive, as the data suggest, this casts doubt on claims125,143 that 
the frequency of embryonic abnormalities observed in vitro is rep-
resentative of the natural in vivo situation. In turn, this implies that 
many of the chromosomal abnormalities observed in in vitro human 
embryos may be, to a greater extent than currently recognised125, an 
artefact of the clinical and experimental interventions of assisted 
reproductive technologies.
This is not the first time that attention has been drawn to unsatisfac-
tory estimates of early embryo loss. Faced with some of the same 
data, others have noted that “a claim of ‘no significant difference’ 
might easily be sustained against any interpretation proffered”16 
and that estimates are “difficult to defend with any precision”10. 
Conclusions have been based on “poor estimates of fertiliza-
tion failure rate and the mortality at 2 weeks after fertilisation”23 
and drawn “from unusual or biased samples”150. Nevertheless, 
although precision may be elusive, exaggeration can be avoided. It 
is hoped that this critical re-evaluation of the data describing early 
human embryo mortality will serve as a robust foundation upon 
which to make informed biological, ethical, legal and personal 
judgements.
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